Even prior to the identification of the transcription factor Foxp3 as the canonical driver of Tregs, seminal work found that depletion of CD25+ T cells (a subset of which are Tregs) before tumor implantation can lead to enhanced antitumor immune responses and eventual spontaneous tumor rejection77. Here, FOXP3 is linked to neoplasm.